Kurt A. Dasse,Priscilla C. Petit,David H. Fine,Gregory Vasquez
申请号：
US15382601
公开号：
US20170182088A1
申请日:
2016.12.16
申请国别(地区):
US
年份:
2017
代理人:
摘要：
A method of providing a therapeutic composition includes administering a ROS reducing drug, calcium channel blocker, anti-fibrotic, anti-inflammatory, or anti-hypertensive drug and administering inhaled nitric oxide and reducing symptoms of oxidative stress and/or fibrosis in a patient.
